HIGHBRIDGE CAPITAL MANAGEMENT LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2017$313,000
-88.2%
472,553
-89.7%
0.01%
-85.0%
Q3 2017$2,657,000
+11452.2%
4,580,669
+26531.8%
0.04%
Q1 2017$23,000
-98.9%
17,200
-99.6%
0.00%
-100.0%
Q4 2016$2,127,000
+2289.9%
4,779,800
+20722.5%
0.04%
+3700.0%
Q4 2013$89,00022,9550.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,825,000$1,206,0000.39%
Zhang Financial LLC 45,000$33,0000.02%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 472,553$313,0000.01%
MEITAV INVESTMENT HOUSE LTD 127,062$85,0000.01%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 324,479$215,000,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$200,0000.00%
Renaissance Technologies 1,993,500$1,318,0000.00%
WEDBUSH SECURITIES INC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 57,127$38,0000.00%
Psagot Value Holdings Ltd. 29,193$20,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders